Inactive Instrument
Phosphagenics Limited Stock Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 68.95M 47.61M 41.74M 38.48M 36.02M 67.55M 4.49B 462M 179M 2.22B 179M 175M 7.7B | P/E 2024 |
-2.5x | P/E 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 64.3M 44.4M 38.93M 35.88M 33.59M 62.99M 4.19B 431M 167M 2.07B 167M 163M 7.18B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
75.85% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 01/05/2020 |
Roksan Libinaki
COO | Chief Operating Officer | - | 01/05/2020 |
Naomi Lawrie
SEC | Corporate Secretary | - | 01/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 13/04/2015 |
Gregory Collier
CHM | Chairman | - | 01/01/2019 |
Kathy Connell
BRD | Director/Board Member | 59 | 26/04/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 47.61M | ||
| +7.13% | +9.97% | +55.80% | +163.38% | 1,077B | ||
| +3.99% | +11.50% | +67.09% | +56.27% | 613B | ||
| +4.20% | +17.03% | +38.97% | +91.19% | 448B | ||
| +0.99% | +4.85% | +28.17% | +22.04% | 332B | ||
| +1.82% | +8.19% | +40.04% | +27.45% | 293B | ||
| +0.22% | +6.75% | +31.30% | +42.64% | 286B | ||
| +0.73% | +8.53% | -27.33% | -40.29% | 215B | ||
| +1.56% | +6.14% | +29.30% | +61.91% | 193B | ||
| +3.26% | +3.33% | +15.55% | +67.87% | 159B | ||
| Average | +0.96% | +8.48% | +30.99% | +54.72% | 401.79B | |
| Weighted average by Cap. | +3.85% | +9.65% | +41.75% | +81.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 782K 686K 632K 592K 1.11M 73.77M 7.6M 2.94M 36.46M 2.94M 2.87M 126M | 1.24M 855K 749K 691K 647K 1.21M 80.62M 8.3M 3.21M 39.84M 3.21M 3.14M 138M |
| Net income | -3.12M -2.16M -1.89M -1.74M -1.63M -3.06M -203M -20.94M -8.1M -101M -8.09M -7.92M -348M | -4.42M -3.05M -2.67M -2.46M -2.31M -4.33M -288M -29.62M -11.46M -142M -11.45M -11.2M -493M |
| Net Debt | -1.3M -896K -786K -724K -678K -1.27M -84.53M -8.71M -3.37M -41.78M -3.36M -3.29M -145M | -4.65M -3.21M -2.81M -2.59M -2.43M -4.55M -303M -31.18M -12.07M -150M -12.05M -11.79M -519M |
Employees
-
Sector
Pharmaceuticals
















